Centre Hospitalier Annecy Genevois

Recent papers from Centre Hospitalier Annecy Genevois

1. Complete small bowel and mesenteric avulsion following rope-compression blunt abdominal trauma after a fall from height: a case reportInternational Journal of Surgery Case Reports · 2026
2. Three-fraction preoperative stereotactic radiotherapy for resectable brain metastases: the phase 2 STEP trialNeuro-Oncology · 2026
3. Interpretability of the Quantra viscoelastic test in patients with haematological malignancies presenting severe thrombocytopeniaBlood Coagulation & Fibrinolysis · 2026
4. Rituximab vs Azathioprine for Eosinophilic Granulomatosis With Polyangiitis Maintenance TherapyJAMA · 2026
5. Nivolumab added to cisplatin and radiotherapy versus cisplatin and radiotherapy alone after surgery for people with squamous cell carcinoma of the head and neck at a high risk of relapse (GORTEC 2018-01 NIVOPOST-OP): a randomised, open-label, phase 3 trialThe Lancet · 2025
6. Infective Endocarditis in Solid Organ and Haematopoietic Stem Cell Transplant Recipients (E-IPA Study): a propensity-score-matched retrospective cohort studyClinical Infectious Diseases · 2026
7. Intermittent or Continuous Renal-Replacement Therapy in Acute Kidney InjuryNew England Journal of Medicine · 2026
8. Subcutaneous isatuximab by on-body-injector plus bortezomib, lenalidomide, and dexamethasone in newly diagnosed transplant-ineligible multiple myeloma: ISASOCUT studyBlood Cancer Journal · 2026
9. Favorable Functional Outcomes and Low Instability Recurrence Rates After the Latarjet Procedure in Adolescent Patients: A Systematic ReviewArthroscopy The Journal of Arthroscopic and Related Surgery · 2026
10. Kidney-Alone Transplantation with siRNA Therapy in Primary Hyperoxaluria Type 1Kidney International Reports · 2026
11. End-of-induction circulating tumor DNA outperforms conventional cellular MRD for predicting early progression in follicular lymphoma: an ancillary study of the RELEVANCE randomized trialBlood Cancer Journal · 2026
12. Low-dose deferasirox for lower-risk myelodysplastic syndromes after erythropoiesis-stimulating agents (ESA) failure: results of the phase II LODEFI studyHaematologica · 2026
13. Lanreotide, a Somatostatin Analogue, in Advanced Merkel Cell Carcinoma: A Prospective Single‐Arm Phase II StudyCancer Medicine · 2026
14. Genetic landscape of a neonatal hypogonadotropic hypogonadism series: Novel variants and phenotypic spectrumJournal of Neuroendocrinology · 2026
15. Lenalidomide maintenance after initial immunochemotherapy in chronic lymphocytic leukaemia—Final analysis of the international phase III CLL6 RESIDUUM study of the ALLG and FILO groupsBritish Journal of Haematology · 2026
16. Real-World Utilization of the Novavax Adjuvanted Recombinant Protein COVID-19 Vaccine in France During the 2022–2024 PeriodVaccines · 2026
17. From fluid loss to calcification: MRI and CT matrix features in cystic echinococcosisInsights into Imaging · 2026
18. Data from the French Daily-Luma cohort suggest predictors of a lumasiran responseKidney International · 2026
19. Fractional Flow Reserve to Guide Treatment of Patients With Multivessel Coronary Artery DiseaseJournal of the American College of Cardiology · 2021
20. The MYOSAIQ Challenge: Myocardial Segmentation with Automated Infarct QuantificationThe Journal of Machine Learning for Biomedical Imaging · 2026